Cutler Group LLC / CA - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,000
+200.0%
5,400
+1700.0%
0.00%
Q3 2020$1,000
-91.7%
300
-78.9%
0.00%
-100.0%
Q2 2020$12,0000.0%1,420
+77.5%
0.00%0.0%
Q1 2020$12,000
-36.8%
800
-20.0%
0.00%0.0%
Q4 2019$19,000
+850.0%
1,000
+400.0%
0.00%
Q4 2018$2,000
-83.3%
200
-80.0%
0.00%
-100.0%
Q2 2018$12,0001,000
+100.0%
0.00%
Q1 2018$05000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders